From the Desk of the EMD: COVID-19 and the allergist
During a recent haircut, my barber, who knows I’m a physician, wanted to know about the coronavirus and what she should do. She was hoping that the extra vitam…
Your Leadership’s Decisions
The following are key actions taken by the Board of Regents at the Nov. 7 meeting and by the Executive Committee during its Dec. 17 teleconference.Approved the…
Explore opportunities to share your expertise
Are you looking for a new way to become involved with the College? We’re taking applications through April 15 to fill committee openings that w…
Spotlight on the Women in Allergy Committee
The Women in Allergy Committee has been revamped to more heavily focus on issues of importance to women allergists. Its new purpose is to promote inv…
Your questions answered
We asked Michael Blaiss, MD, FACAAI, executive medical director, to comment on the recent member survey and how the College is using this information to plan i…
The data is in
The College is pleased to announce the latest update of Asthma Management and the Allergist: Better Outcomes at Lower Cost. This College publication, also know…
Drug-induced anaphylaxis, mast cell activation syndrome and the ICON on ocular allergy
The days are getting longer as we get closer to the spring allergy season. Although our emphasis in this month’s issue of the Annals of Allergy, Asthma and Imm…
Are you informed about informed consent?
Pop quiz: what is informed consent, when is it required for allergy practices, and how exactly should it be done? Some physicians and practices have adopted a …
A new era in allergy treatment
As we enter a new era in allergy treatment with the release of the first Food and Drug Administration (FDA)-approved product to treat peanut allergy, I wanted …
The College’s revitalized House of Delegates
We’re reinvigorating the College's House of Delegates (HOD) to provide a closer connection between the College/Advocacy Council and member allergists…
